Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid Xaar (XAR) by Steve Moore in ShareProphets
- Avoid Lifesafe Holdings (LIFS) by Steve Moore in ShareProphets
- Buy Smith & Nephew (SN.) by Berenberg
- Hold Mitchells & Butlers (MAB) by Shore Capital
- Buy Iofina (IOF) by Canaccord Genuity
- Speculative Buy GB Group (GBG) by Canaccord Genuity
- Hold NCC Group (NCC) by Shore Capital
- Sell Future (FUTR) by Canaccord Genuity
- Buy Harmony Energy Income Trust (HEIT) by Berenberg
- Buy Me Group International (MEGP) by Berenberg
- Neutral easyJet (EZJ) by JP Morgan
- Outperform The Renewables Infrastructure Group Limited (TRIG) by RBC Capital
- Underweight Lloyds Banking Group (LLOY) by JP Morgan
- Buy EnQuest (ENQ) by Gary Newman in ShareProphets
- Buy Halfords Group (HFD) by Chris Bailey in ShareProphets
- Buy ITV (ITV) by Christopher Ruane in The Motley Fool
- Buy Legal & General Group (LGEN) by Christopher Ruane in The Motley Fool
- Buy Diageo (DGE) by Christopher Ruane in The Motley Fool
- Buy Phoenix Group Holdings (PHNX) by Simon Watkins in The Motley Fool
- Sell Abrdn (ABDN) by UBS
Physiomics (PYC) Share Price
Health Care Sector
NOTE: This is based on 13 open tips for Physiomics (PYC)
| Latest Bid : 1.60p | Latest Ask : 1.70p |
| High Today : 1.65p | Low Today : 1.60p |
| This Years High : 5.10p | This Years Low : 0.95p |
| Volume : 51,423 | MKT Cap : £2.23M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Stock Splits and Consolidations
19/12/2016 – Stock Consolidation 100.000:1.000
Physiomics (PYC) Overview
Physiomics' vision is to transform oncology drug development. We believe in innovation, collaboration, diversity and inclusion and we aim to bring out the best in each other, in order to help our partners develop great cancer drugs and to apply them optimally in real-world settings.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Physiomics (PYC) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Avoid | Steve Moore | Premium Only | 2023-11-10 13:55:00 10/11/2023 | -10.00% |
| Avoid | Steve Moore | Premium Only | 2023-09-01 16:10:00 01/09/2023 | -3.13% |
| Avoid | Steve Moore | Premium Only | 2023-08-04 16:00:00 04/08/2023 | -73.68% |
| Avoid | Steve Moore | Premium Only | 2023-06-27 11:10:00 27/06/2023 | -65.00% |
| Avoid | Steve Moore | Premium Only | 2023-05-31 14:50:00 31/05/2023 | 8.33% |
Physiomics (PYC) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 1.60p | Latest Ask : 1.70p |
| High Today : 1.65p | Low Today : 1.60p |
| This Years High : 5.10p | This Years Low : 0.95p |
| Volume : 51,423 | MKT Cap : £2.23M |
Physiomics Overview
Physiomics' vision is to transform oncology drug development. We believe in innovation, collaboration, diversity and inclusion and we aim to bring out the best in each other, in order to help our partners develop great cancer drugs and to apply them optimally in real-world settings.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Physiomics Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Avoid | Steve Moore | Premium Only | 2023-11-10 13:55:00 10/11/2023 | -10.00% |
| Avoid | Steve Moore | Premium Only | 2023-09-01 16:10:00 01/09/2023 | -3.13% |
| Avoid | Steve Moore | Premium Only | 2023-08-04 16:00:00 04/08/2023 | -73.68% |
| Avoid | Steve Moore | Premium Only | 2023-06-27 11:10:00 27/06/2023 | -65.00% |
| Avoid | Steve Moore | Premium Only | 2023-05-31 14:50:00 31/05/2023 | 8.33% |
Stock Splits and Consolidations
19/12/2016 – Stock Consolidation 100.000:1.000